10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2018 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
Revenues | |||
Premiums | $ 36,113 | 32,491 | 30,824 |
Net investment income | 1,480 | 1,226 | 1,147 |
Total revenues | 48,650 | 41,806 | 39,838 |
Benefits and Expenses | |||
Medical costs and other benefit expenses | 27,528 | 25,263 | 24,341 |
Pharmacy and other service costs | 4,793 | 2,456 | 2,468 |
Selling, general and administrative expenses | 11,934 | 10,030 | 9,790 |
Amortization of other acquired intangible assets | 235 | 115 | 151 |
Total operating expenses | 44,490 | 37,864 | 36,750 |
Income from operations | 4,160 | 3,942 | 3,088 |
Interest expense and other | (498) | (252) | (278) |
Debt extinguishment costs | 0 | (321) | 0 |
Net realized investment gains (losses) | (81) | 237 | 169 |
Income (loss) before income taxes | 3,581 | 3,606 | 2,979 |
Total income taxes | 935 | 1,374 | 1,136 |
Net Income | 2,646 | 2,232 | 1,843 |
Less: net income (loss) attributable to noncontrolling interests | 9 | (5) | (24) |
Shareholders' net income | 2,637 | 2,237 | 1,867 |
Shareholders' net income per share: | |||
Basic | 10.69 | 8.92 | 7.31 |
Diluted | 10.54 | 8.77 | 7.19 |
Product Or Service | |||
Fees and other revenues | |||
Pharmacy revenues, fees and other revenues | 5,578 | 5,110 | 4,901 |
Pharmacy revenues | |||
Pharmacy revenues, fees and other revenues | 5,479 | 2,979 | 2,966 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2018 | |||
Consolidated Statements of Shareholders' Comprehensive Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
Shareholders' net income | $ 2,637 | 2,237 | 1,867 |
Shareholders' other comprehensive income (loss), net of tax: | |||
Net unrealized appreciation (depreciation), securities and derivatives | (365) | (37) | (60) |
Net translation (losses) gains on foreign currencies | (152) | 304 | (95) |
Postretirement benefits liability adjustment | 127 | 33 | 23 |
Shareholders' other comprehensive income (loss), net of tax | (390) | 300 | (132) |
Shareholders' comprehensive income (loss) | 2,247 | 2,537 | 1,735 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
Cash Flows from Operating Activities | |||
Net Income | $ 2,646 | 2,232 | 1,843 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | 695 | 566 | 610 |
Realized investment (gains) losses | 81 | (237) | (169) |
Deferred income taxes (benefits) | (101) | 242 | 74 |
Debt extinguishment costs | 0 | 321 | 0 |
Net changes in assets and liabilities, net of non-operating effects: | |||
Accounts receivable | 705 | (233) | 663 |
Inventories | (107) | (72) | 30 |
Deferred policy acquisition costs | (237) | (282) | (213) |
Reinsurance recoverables and other assets | (234) | 115 | 246 |
Insurance liabilities | 560 | 506 | 683 |
Pharmacy and service costs payable | (842) | 35 | (46) |
Accounts payable, accrued expenses and other liabilities | 332 | 696 | 171 |
Other, net | 272 | 197 | 134 |
Net cash provided by (used in) operating activities | 3,770 | 4,086 | 4,026 |
Cash Flows from Investing Activities | |||
Proceeds from investments sold: | |||
Fixed maturities and equity securities | 2,655 | 2,012 | 1,544 |
Investment maturities and repayments: | |||
Fixed maturities and equity securities | 2,151 | 2,051 | 1,755 |
Commercial mortgage loans | 215 | 335 | 316 |
Other sales, maturities and repayments (primarily short-term and other long-term investments) | 734 | 1,702 | 1,431 |
Investments purchased or originated: | |||
Fixed maturities and equity securities | (5,637) | (5,628) | (5,191) |
Commercial mortgage loans | (312) | (430) | (165) |
Other (primarily short-term and other long-term investments) | (1,189) | (1,065) | (1,698) |
Property and equipment purchases | (528) | (471) | (461) |
Acquisitions, net of cash acquired | (24,455) | (209) | (4) |
Other, net | (12) | 0 | (101) |
Net cash provided by (used in) investing activities | (26,378) | (1,703) | (2,574) |
Cash Flows from Financing Activities | |||
Deposits and interest credited to contractholder deposit funds | 1,040 | 1,230 | 1,460 |
Withdrawals and benefit payments from contractholder deposit funds | (1,151) | (1,363) | (1,362) |
Net change in short-term debt | 1,487 | 80 | (148) |
Payments for debt extinguishment | 0 | (313) | 0 |
Repayment of long-term debt | (131) | (1,250) | 0 |
Net proceeds on issuance of long-term debt | 22,856 | 1,581 | 0 |
Repurchase of common stock | (342) | (2,725) | (139) |
Issuance of common stock | 68 | 131 | 36 |
Other, net | (312) | (22) | (72) |
Net cash provided by (used in) financing activities | 23,515 | (2,651) | (225) |
Effect of foreign currency rate changes on cash and cash equivalents | (24) | 55 | (10) |
Net increase / (decrease) in cash and cash equivalents | 883 | (213) | 1,217 |
Cash and cash equivalents, January 1, | 2,972 | 3,185 | |
Cash and cash equivalents, December 31, | 3,855 | 2,972 | 3,185 |
Supplemental Disclosure of Cash Information: | |||
Income taxes paid, net of refunds | 1,019 | 1,036 | 1,064 |
Interest paid | 267 | 240 | 244 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CIGNA GROUP | ||
Ticker: CI Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2018 | Dec 31, 2017 | |
Assets | ||
Cash and cash equivalents | $ 3,855 | 2,972 |
Investments | 2,045 | 2,136 |
Accounts receivable, net | 10,473 | 3,155 |
Inventories | 2,821 | 228 |
Other current assets | 1,236 | 820 |
Total current assets | 20,430 | 9,311 |
Long-term investments | 26,929 | 26,483 |
Reinsurance recoverables | 5,507 | 5,763 |
Deferred policy acquisition costs | 2,821 | 2,237 |
Property and equipment | 4,562 | 1,563 |
Deferred tax assets, net | 0 | 39 |
Goodwill | 44,505 | 6,164 |
Other intangible assets | 39,003 | 345 |
Other assets | 1,630 | 1,431 |
Separate account assets | 7,839 | 8,423 |
TOTAL ASSETS | 153,226 | 61,759 |
Liabilities: | ||
Current insurance and contractholder liabilities | 6,801 | 6,317 |
Pharmacy and service costs payable | 10,702 | 305 |
Accounts payable | 4,366 | 184 |
Accrued expenses and other liabilities | 7,071 | 3,963 |
Short-term debt | 2,955 | 240 |
Total current liabilities | 31,895 | 11,009 |
Non-current insurance and contractholder liabilities | 19,974 | 20,530 |
Deferred tax liabilities, net | 9,453 | 0 |
Other non-current liabilities | 3,470 | 2,838 |
Long-term debt | 39,523 | 5,199 |
Separate account liabilities | 7,839 | 8,423 |
TOTAL LIABILITIES | 112,154 | 47,999 |
Redeemable noncontrolling interests | 37 | 49 |
Shareholders' Equity | ||
Common stock | 4 [1] | 74 |
Additional paid-in capital | 27,751 | 2,940 |
Accumulated other comprehensive income (loss) | (1,711) | (1,082) |
Retained earnings | 15,088 | 15,800 |
Less: treasury stock, at cost | (104) | (4,021) |
TOTAL SHAREHOLDERS' EQUITY | 41,028 | 13,711 |
Noncontrolling interests | 7 | 0 |
Total equity | 41,035 | 13,711 |
Total liabilities and shareholders' equity | 153,226 | 61,759 |
Shareholders' Equity Per Share | 107.71 | 56.20 |
[1] Par value per share, $0.01 in 2018 and $0.25 in 2017; shares issued, 381 million in 2018 and 296 million in 2017; authorized shares, 600 million in 2018 and 2017. |
External Links | |
CIGNA GROUP (CI) Fiscal Year 2018 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |